This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Bilban M, Heintel D, Scharl T, Woelfel T, Auer MM, Porpaczy E et al. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia 2006; 20: 1080–1088.
Heintel D, Kienle D, Shehata M, Krober A, Kroemer E, Schwarzinger I et al. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 2005; 19: 1216–1223.
Bomben R, Dal BM, Capello D, Benedetti D, Marconi D, Zucchetto A et al. Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study. Blood 2007; 109: 2989–2998.
Tobin G, Thunberg U, Johnson A, Thorn I, Soderberg O, Hultdin M et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002; 99: 2262–2264.
Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stella S, Guida G et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005; 105: 1678–1685.
van't Veer MB, Brooijmans AM, Langerak AW, Verhaaf B, Goudswaard CS, Graveland WJ et al. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 2006; 91: 56–63.
Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007; 109: 259–270.
Del Principe MI, Del PG, Buccisano F, Maurillo L, Venditti A, Zucchetto A et al. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 2006; 108: 853–861.
Acknowledgements
This work was supported in part by Ministero della Salute (Ricerca Finalizzata IRCCS and ‘Alleanza Contro il Cancro’), Rome; Programmi di Ricerca di Interesse Nazionale (PRIN) and Fondo per gli Investimenti per la Ricerca di Base (FIRB), MUR, Rome; Associazione Italiana contro le Leucemie linfomi e mielomi (AIL)—Venezia, Pramaggiore group (fellowship to MDB); Novara-AIL Onlus, Novara; Ricerca Scientifica Applicata Regione Piemonte, Torino.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Benedetti, D., Bomben, R., Dal-Bo, M. et al. Are surrogates of IGHV gene mutational status useful in B-cell chronic lymphocytic leukemia? The example of Septin-10. Leukemia 22, 224–226 (2008). https://doi.org/10.1038/sj.leu.2404867
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404867